These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1868461)

  • 1. Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors.
    Miller BE; Machemer T; Lehotan M; Heppner GH
    Cancer Res; 1991 Aug; 51(16):4378-87. PubMed ID: 1868461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1985 Sep; 45(9):4200-5. PubMed ID: 4028010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors.
    Miller BE; Miller FR; Wilburn D; Heppner GH
    Cancer Res; 1988 Oct; 48(20):5747-53. PubMed ID: 3167832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1989 Jul; 49(14):3747-53. PubMed ID: 2736515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts.
    Miller FR; McEachern D; Miller BE
    Cancer Res; 1989 Nov; 49(21):6091-7. PubMed ID: 2790822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of extracellular matrix on the growth and casein gene expression of primary mouse mammary tumor cells in vitro.
    Chou JL; Shen ZX; Stolfi RL; Martin DS; Waxman S
    Cancer Res; 1989 Oct; 49(19):5371-6. PubMed ID: 2766303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of development of methotrexate resistance in heterogeneous mouse mammary tumor cell cultures.
    Miller BE; Matherly LH; Lehotan M; Heppner GH
    J Exp Ther Oncol; 1996 Jan; 1(1):30-8. PubMed ID: 9414386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy.
    Emerman JT; Siemiatkowski J
    Cancer Res; 1984 Apr; 44(4):1327-32. PubMed ID: 6704951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor.
    Miller BE; Miller FR; Leith J; Heppner GH
    Cancer Res; 1980 Nov; 40(11):3977-81. PubMed ID: 7471048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor subpopulation interactions in metastasis.
    Miller FR
    Invasion Metastasis; 1983; 3(4):234-42. PubMed ID: 6677628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
    Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P
    Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
    Tofilon PJ; Basic I; Milas L
    Cancer Res; 1985 May; 45(5):2025-30. PubMed ID: 4039220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
    Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
    Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the proliferative response to lysophosphatidic acid in primary cultures of mammary epithelium: differences between normal and tumor cells.
    Imagawa W; Bandyopadhyay GK; Nandi S
    Exp Cell Res; 1995 Jan; 216(1):178-86. PubMed ID: 7813618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melphalan sensitivity as a function of progressive metastatic growth in two subpopulations of a mouse mammary tumour.
    Miller BE; Miller FR; Machemer T; Heppner GH
    Br J Cancer; 1993 Jul; 68(1):18-25. PubMed ID: 8318410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen-production inhibitors evaluated as antitumor agents.
    Klohs WD; Steinkampf RW; Wicha MS; Mertus AE; Tunac JB; Leopold WR
    J Natl Cancer Inst; 1985 Aug; 75(2):353-9. PubMed ID: 3860688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma.
    Alonso DF; Farías EF; Urtreger A; Ladeda V; Vidal MC; Bal De Kier Joffé E
    J Surg Oncol; 1996 Aug; 62(4):288-97. PubMed ID: 8691844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of mouse mammary epithelial cells grown in primary collagen gel cultures.
    Guzman RC; Osborn RC; Yang J; DeOme KB; Nandi S
    Cancer Res; 1982 Jun; 42(6):2376-83. PubMed ID: 7074616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.